Barclays analyst Ramsey El-Assal maintains Green Dot (NYSE:GDOT) with a Equal-Weight and lowers the price target from $21 to $19.
GoodRx Plunges As Q4 Fall Short Of Expectations, Analysts Cut Price Target
Consumer-focused digital healthcare, GoodRx Holdings Inc (NASDAQ: GDRX) shares are plunging after the company's